Teva's Generic EpiPen Will Cost As Much As Mylan's Generic | Time
Teva Issues New Letter to Mylan NV Confirming Seriousness Of Offer To Acquire Mylan - Jewish Business News
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
Teva gains leverage in pursuit of Mylan | Pittsburgh Post-Gazette
Generic EpiPen Cleared By FDA As Teva Challenges Mylan
Israel-Based Teva Pharmaceutical Industries Smacks Down With Mylan With $40B Bid - YouTube
Mylan board rejects Teva takeover bid
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Big blow for Teva as FDA approves Mylan's generic Copaxone - Globes
Teva Offers to acquire Mylan for $40 billion in cash, stock | Pharma Companies
US lawmakers push Mylan, Teva over drug pricing probe - www.israelhayom.com
Mylan, Generic Copaxone Punish Teva (NYSE:TEVA) | Seeking Alpha
Where a Teva-Mylan Deal Would Rank Among Big Pharma Companies
Teva or Mylan: Who Has the More Promising Revenue Trajectory?
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva wins FDA nod for its generic of Mylan's EpiPen after 2-year delay | Fierce Pharma
Mylan NDEA contamination prompts Teva recall in US
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
$40B deal: Teva offers to buy Mylan
Mylan Should Try Teva On for Size - WSJ
Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
How Mylan tried to keep Teva from selling a generic EpiPen
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma
